Real‐world causal evidence for planned predictive enrichment in critical care trials: A scoping review

Abstract

BackgroundRandomised clinical trials in critical care are prone to inconclusiveness due, in part, to undue optimism about effect sizes and suboptimal accounting for heterogeneous treatment effects. Although causal evidence from rich real‐world critical care can help overcome these challenges by informing predictive enrichment, no overview exists.MethodsWe conducted a scoping review, systematically searching 10 general and speciality journals for reports published on or after 1 January 2018, of randomised clinical trials enrolling adult critically ill patients. We collected trial metadata on 22 variables including recruitment period, intervention type and early stopping (including reasons) as well as data on the use of causal evidence from secondary data for planned predictive enrichment.ResultsWe screened 9020 records and included 316 unique RCTs with a total of 268,563 randomised participants. One hundred seventy‐three (55%) trials tested drug interventions, 101 (32%) management strategies and 42 (13%) devices. The median duration of enrolment was 2.2 (IQR: 1.3–3.4) years, and 83% of trials randomised less than 1000 participants. Thirty‐six trials (11%) were restricted to COVID‐19 patients. Of the 55 (17%) trials that stopped early, 23 (42%) used predefined rules; futility, slow enrolment and safety concerns were the commonest stopping reasons. None of the included RCTs had used causal evidence from secondary data for planned predictive enrichment.ConclusionWork is needed to harness the rich multiverse of critical care data and establish its utility in critical care RCTs. Such work will likely need to leverage methodology from interventional and analytical epidemiology as well as data science.